Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cucchetti

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|December 2, 2008
Liver transplantations with donors aged 60 years and above: the low liver damage strategyMatteo Ravaioli, Gian Luca Grazi, Matteo Cescon, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 23, 2018
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver TransplantationAndrea Ruzzenente, Fabio Bagante, Francesca Bertuzzo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2021
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenibMargherita Rimini, Changoon Yoo, Sara Lonardi, et al.
Journal of Hepatology|September 22, 2018
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionAnthony W H Chan, Jianhong Zhong, Sarah Berhane, et al.
The Oncologist|November 4, 2016
In ReplyGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Cancers|July 24, 2019
<i>ANGPT2</i> and <i>NOS3</i> Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving SorafenibGiorgia Marisi, Elisabetta Petracci, Francesco Raimondi, et al.
The Oncologist|April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
International Journal of Molecular Sciences|March 29, 2019
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with MetforminSerena De Matteis, Emanuela Scarpi, Anna Maria Granato, et al.
Transplantation|September 17, 2024
Transarterial Radioembolization Can Downstage Intermediate and Advanced Hepatocellular Carcinoma to Liver TransplantationGiammauro Berardi, Nicola Guglielmo, Alessandro Cucchetti, et al.
Gastrointestinal Tumors|November 27, 2019
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of ExperienceGiulia Rovesti, Giulia Orsi, Andrikou Kalliopi, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Transplant International : Official Journal of the European Society for Organ Transplantation|December 2, 2008
Liver transplantations with donors aged 60 years and above: the low liver damage strategyMatteo Ravaioli, Gian Luca Grazi, Matteo Cescon, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 23, 2018
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver TransplantationAndrea Ruzzenente, Fabio Bagante, Francesca Bertuzzo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2021
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenibMargherita Rimini, Changoon Yoo, Sara Lonardi, et al.
Journal of Hepatology|September 22, 2018
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionAnthony W H Chan, Jianhong Zhong, Sarah Berhane, et al.
The Oncologist|November 4, 2016
In ReplyGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Cancers|July 24, 2019
<i>ANGPT2</i> and <i>NOS3</i> Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving SorafenibGiorgia Marisi, Elisabetta Petracci, Francesco Raimondi, et al.
The Oncologist|April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
International Journal of Molecular Sciences|March 29, 2019
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with MetforminSerena De Matteis, Emanuela Scarpi, Anna Maria Granato, et al.
Transplantation|September 17, 2024
Transarterial Radioembolization Can Downstage Intermediate and Advanced Hepatocellular Carcinoma to Liver TransplantationGiammauro Berardi, Nicola Guglielmo, Alessandro Cucchetti, et al.
Gastrointestinal Tumors|November 27, 2019
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of ExperienceGiulia Rovesti, Giulia Orsi, Andrikou Kalliopi, et al.
Pageof 31